SPONSOR
National Cancer Center, Japan
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Low-grade GliomaPancreatic CancerAdvanced or Recurrent Solid TumorsFGFR Gene AlterationsHER2-positive Breast Cancer
National Cancer Center, Japan is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Low-grade Glioma, Pancreatic Cancer, Advanced or Recurrent Solid Tumors, FGFR Gene Alterations.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Cancer Center, Japan
How many clinical trials has National Cancer Center, Japan sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by National Cancer Center, Japan, of which 3 are actively recruiting participants. These trials cover conditions including Low-grade Glioma, Pancreatic Cancer, Advanced or Recurrent Solid Tumors. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Cancer Center, Japan research focus on?
National Cancer Center, Japan clinical trials span Low-grade Glioma, Pancreatic Cancer, Advanced or Recurrent Solid Tumors, FGFR Gene Alterations, HER2-positive Breast Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Cancer Center, Japan clinical trial?
To participate in a National Cancer Center, Japan trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Cancer Center, Japan trials with current recruitment status updated daily.
Clinical Trials by National Cancer Center, Japan
NCT06159478 Phase 2
Recruiting
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Low-grade Glioma
NCT04962867 Phase 2
Recruiting
NCCH2006/MK010 Trial (FORTUNE Trial)
Advanced or Recurrent Solid Tumors
NCT05433753
Recruiting
Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study
HER2-positive Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology